Skip to Content

Furoscix FDA Approval Status

Last updated by Judith Stewart, BPharm on July 6, 2020.

FDA Approved: No
Brand name: Furoscix
Generic name: furosemide
Company: scPharmaceuticals, Inc.
Treatment for: Heart Failure

Furoscix (furosemide) is a subcutaneous formulation of the approved diuretic furosemide delivered via a wearable, pre-programmed on-body drug delivery system. Furoscix is in development for treatment of congestion in patients with heart failure, and has the potential to provide an outpatient alternative for the treatment of worsening heart failure due to congestion.

Development Timeline for Furoscix

DateArticle
Dec  7, 2020scPharmaceuticals Inc. Receives Complete Response Letter from FDA for Furoscix
Jul 27, 2020scPharmaceuticals Announces FDA Acceptance of Furoscix New Drug Application Resubmission
Jul  1, 2020scPharmaceuticals Announces Furoscix NDA Resubmission
Jun 13, 2018scPharmaceuticals Receives Complete Response Letter from the FDA for Furoscix

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.